De novo mutations in the X-linked TFE3 gene cause intellectual disability with pigmentary mosaicism and storage disorder-like features
- 14 May 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 57 (12), 808-819
- https://doi.org/10.1136/jmedgenet-2019-106508
Abstract
Introduction Pigmentary mosaicism (PM) manifests by pigmentation anomalies along Blaschko’s lines and represents a clue toward the molecular diagnosis of syndromic intellectual disability (ID). Together with new insights on the role for lysosomal signalling in embryonic stem cell differentiation, mutations in the X-linked transcription factor 3 (TFE3) have recently been reported in five patients. Functional analysis suggested these mutations to result in ectopic nuclear gain of functions. Materials and methods Subsequent data sharing allowed the clustering of de novo TFE3 variants identified by exome sequencing on DNA extracted from leucocytes in patients referred for syndromic ID with or without PM. Results We describe the detailed clinical and molecular data of 17 individuals harbouring a de novo TFE3 variant, including the patients that initially allowed reporting TFE3 as a new disease-causing gene. The 12 females and 5 males presented with pigmentation anomalies on Blaschko’s lines, severe ID, epilepsy, storage disorder-like features, growth retardation and recognisable facial dysmorphism. The variant was at a mosaic state in at least two male patients. All variants were missense except one splice variant. Eleven of the 13 variants were localised in exon 4, 2 in exon 3, and 3 were recurrent variants. Conclusion This series further delineates the specific storage disorder-like phenotype with PM ascribed to de novo TFE3 mutation in exons 3 and 4. It confirms the identification of a novel X-linked human condition associated with mosaicism and dysregulation within the mechanistic target of rapamycin (mTOR) pathway, as well as a link between lysosomal signalling and human development.Keywords
Funding Information
- Programme Hospitalier de Recherche Clinique (PHRC) National 2010 (NCT01950975)
- URDCat program (PERIS SLT002/16/00174)
- Ministerio de Economia, Industria y Competividad (Juan de la Cierva programme FJCI-2016-28811)
- Agence Nationale de Recherche (ANR-13-PDOC-0029)
This publication has 43 references indexed in Scilit:
- Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasisCellular and Molecular Life Sciences, 2014
- The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular DebrisScience Signaling, 2014
- TFE3 Controls Lipid Metabolism in Adipose Tissue of Male Mice by Suppressing Lipolysis and ThermogenesisEndocrinology, 2013
- Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3Cell, 2013
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephalyNature Genetics, 2012
- Embryonic expression of zebrafish MiT family genes tfe3b, tfeb, and tfecDevelopmental Dynamics, 2011
- X-inactivation profile reveals extensive variability in X-linked gene expression in femalesNature, 2005
- Survival of Male Patients with Incontinentia Pigmenti Carrying a Lethal Mutation Can Be Explained by Somatic Mosaicism or Klinefelter SyndromeAmerican Journal of Human Genetics, 2001
- microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.Genes & Development, 1994
- Hypomelanosis of Ito: A Description, Not a Diagnosis.Journal of Investigative Dermatology, 1994